Knowledge, attitude and practices of Saudi pharmacists regarding CVD risk factors and associated barriers.

IF 0.7 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Md Sayeed Akhtar, Sirajudeen Shaik Alavudeen, Khalid Orayj, Fauzia Tabassum, Salem Salman Almujri, Abdulrahman Alshaiban, Abubakr Taha Mohammed Hussain, Azfar Athar Ishaqui, Sultan M Alshahrani
{"title":"Knowledge, attitude and practices of Saudi pharmacists regarding CVD risk factors and associated barriers.","authors":"Md Sayeed Akhtar, Sirajudeen Shaik Alavudeen, Khalid Orayj, Fauzia Tabassum, Salem Salman Almujri, Abdulrahman Alshaiban, Abubakr Taha Mohammed Hussain, Azfar Athar Ishaqui, Sultan M Alshahrani","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Risk assessment for cardiovascular diseases (CVD) is fundamental to prevention, enabling early intervention when risks are recognized. This cross-sectional study focuses on evaluating the knowledge, attitude, practices and perceived barriers of Saudi pharmacists regarding CVD risk factors. A self-administered survey was employed to collect the responses from the participants over a period of four months. Approximately 91% of the participants had completed their graduations and 49.4% of the participants had an experience of less than 5 years. Only 23.1% and 40.1% of the participants reported possessing functional sphygmomanometer and glucometer in their pharmacies, respectively, as a point of care tools. A high level of positive attitude was significantly (P=0.014) associating the level of education. The study identified several barriers influencing the CVD prevention services during pharmaceutical care. The top three barriers were lack of time (66.4%), lack of privacy (58.6%) and lack of tools (59.9%). Despite inadequate knowledge and barriers, a favourable attitude CVD prevention was observed. Thus, pharmacists' CVD risk assessment and preventive hurdles must be addressed. In addition to the Ministry of Health (MoH)'s recent public policy measures, healthcare workers should receive ongoing education and training on CVD prevention and treatment.</p>","PeriodicalId":19971,"journal":{"name":"Pakistan journal of pharmaceutical sciences","volume":"38 1","pages":"15-24"},"PeriodicalIF":0.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan journal of pharmaceutical sciences","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Risk assessment for cardiovascular diseases (CVD) is fundamental to prevention, enabling early intervention when risks are recognized. This cross-sectional study focuses on evaluating the knowledge, attitude, practices and perceived barriers of Saudi pharmacists regarding CVD risk factors. A self-administered survey was employed to collect the responses from the participants over a period of four months. Approximately 91% of the participants had completed their graduations and 49.4% of the participants had an experience of less than 5 years. Only 23.1% and 40.1% of the participants reported possessing functional sphygmomanometer and glucometer in their pharmacies, respectively, as a point of care tools. A high level of positive attitude was significantly (P=0.014) associating the level of education. The study identified several barriers influencing the CVD prevention services during pharmaceutical care. The top three barriers were lack of time (66.4%), lack of privacy (58.6%) and lack of tools (59.9%). Despite inadequate knowledge and barriers, a favourable attitude CVD prevention was observed. Thus, pharmacists' CVD risk assessment and preventive hurdles must be addressed. In addition to the Ministry of Health (MoH)'s recent public policy measures, healthcare workers should receive ongoing education and training on CVD prevention and treatment.

心血管疾病(CVD)的风险评估是预防的基础,可以在发现风险时及早干预。这项横断面研究的重点是评估沙特药剂师对心血管疾病风险因素的认识、态度、实践和感知障碍。研究采用自填式调查的方式,在四个月内收集参与者的反馈。约 91% 的参与者已完成学业,49.4% 的参与者工作经验不足 5 年。只有 23.1%和 40.1%的参与者表示,他们的药房分别拥有功能性血压计和血糖仪作为医疗点工具。高水平的积极态度与受教育程度密切相关(P=0.014)。研究发现了在药物治疗过程中影响心血管疾病预防服务的几个障碍。排在前三位的障碍分别是缺乏时间(66.4%)、缺乏隐私(58.6%)和缺乏工具(59.9%)。尽管存在知识不足和障碍,药剂师对心血管疾病预防仍持积极态度。因此,必须解决药剂师的心血管疾病风险评估和预防障碍。除了卫生部(MoH)最近采取的公共政策措施外,医护人员还应不断接受有关心血管疾病预防和治疗的教育和培训。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.40
自引率
12.50%
发文量
211
审稿时长
4.5 months
期刊介绍: Pakistan Journal of Pharmaceutical Sciences (PJPS) is a peer reviewed multi-disciplinary pharmaceutical sciences journal. The PJPS had its origin in 1988 from the Faculty of Pharmacy, University of Karachi as a biannual journal, frequency converted as quarterly in 2005, and now PJPS is being published as bi-monthly from January 2013. PJPS covers Biological, Pharmaceutical and Medicinal Research (Drug Delivery, Pharmacy Management, Molecular Biology, Biochemical, Pharmacology, Pharmacokinetics, Phytochemical, Bio-analytical, Therapeutics, Biotechnology and research on nano particles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信